Biogen Gets ‘Almost Shockingly Broad’ Label For Alzheimer’s Drug Aducanumab

 
• By Brenda Sandburg
  
Alzheimer's
FDA approves Alzheimer's drug Aducanumab for all stages of the disease. • Source: Alamy
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards